What health risks are associated with low HDL cholesterol?

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

High-density lipoprotein (HDL) cholesterol, often called "good cholesterol," plays a crucial role in protecting your cardiovascular system. When HDL levels drop too low, your body loses a key defense mechanism against heart disease and other serious health conditions. Understanding the risks associated with low HDL cholesterol can help you take proactive steps to protect your health and potentially prevent life-threatening complications.

Low HDL cholesterol affects millions of Americans, with about 18% of adults having dangerously low levels. Men are particularly at risk, with 28.5% having low HDL compared to just 8.9% of women. These statistics represent real people facing increased risks of heart attacks, strokes, and other cardiovascular events that could be prevented with proper awareness and intervention.

Understanding HDL Cholesterol and What Counts as Low

HDL cholesterol functions as your body's cleanup crew, transporting excess cholesterol from your arteries back to your liver for disposal. This reverse cholesterol transport process helps prevent the buildup of dangerous plaque in your blood vessels. HDL particles also carry antioxidant and anti-inflammatory enzymes that provide additional cardiovascular protection.

Medical guidelines define low HDL cholesterol as levels below 40 mg/dL in men and below 50 mg/dL in women. These sex-specific thresholds reflect the fact that women naturally have higher HDL levels, partly due to estrogen's protective effects. When your HDL falls below these levels, you're diagnosed with hypoalphalipoproteinemia, which is recognized as an independent risk factor for coronary heart disease.

The difference in HDL levels between men and women is significant. Premenopausal women typically have HDL levels about 5-10 mg/dL higher than men of the same age. This natural advantage helps explain why women generally have lower rates of heart disease before menopause, though this protection can diminish as estrogen levels decline with age.

Cardiovascular Disease: The Primary Risk

Heart Attack and Coronary Artery Disease

Low HDL cholesterol dramatically increases your risk of coronary artery disease, the leading cause of death in the United States. Landmark studies from Framingham and other major research centers have consistently shown a strong inverse relationship between HDL levels and heart disease risk. For every 1 mg/dL decrease in HDL, your risk of cardiovascular events increases by approximately 2-3%.

When HDL levels are low, less cholesterol gets removed from your arterial walls. This allows cholesterol to accumulate and form dangerous plaques that narrow your arteries. Over time, these plaques can rupture, causing blood clots that block blood flow to your heart muscle, resulting in a heart attack. Research shows that about 63% of patients with coronary artery disease have low HDL levels, highlighting the strong connection between inadequate "good cholesterol" and heart problems.

Stroke and Cerebrovascular Disease

Low HDL cholesterol also increases your risk of stroke, particularly when it affects the carotid arteries that supply blood to your brain. When these crucial blood vessels become narrowed by plaque buildup due to insufficient HDL protection, your brain may not receive adequate oxygen-rich blood. This can lead to transient ischemic attacks (mini-strokes) or full strokes that can cause permanent disability or death.

The relationship between low HDL and stroke risk is particularly concerning because strokes often occur without warning. Unlike heart attacks, which may be preceded by chest pain or other symptoms, strokes can happen suddenly when a blood clot blocks circulation to the brain or when a weakened blood vessel ruptures.

Low HDL cholesterol is one of the five criteria used to diagnose metabolic syndrome, a cluster of conditions that dramatically increases your risk of heart disease, stroke, and type 2 diabetes. When you have low HDL along with other metabolic syndrome components like high blood pressure, elevated blood sugar, excess abdominal fat, and high triglycerides, your health risks multiply exponentially.

People with metabolic syndrome are five times more likely to develop type 2 diabetes and twice as likely to develop heart disease compared to those without the condition. The presence of low HDL in this syndrome indicates that your body's natural cholesterol removal system is compromised, making it harder to prevent the accumulation of harmful lipids in your blood vessels.

Regular monitoring of your cholesterol levels, including HDL, can help identify metabolic syndrome early when interventions are most effective. Comprehensive testing that includes HDL along with other cardiovascular and metabolic markers provides the complete picture needed for proper risk assessment.

Peripheral Artery Disease and Circulation Problems

Low HDL cholesterol contributes to peripheral artery disease (PAD), a condition where plaque buildup narrows the arteries in your legs and arms. PAD is particularly dangerous because it often develops silently, with symptoms only appearing when an artery is at least 60% blocked. By this point, significant damage has already occurred.

The classic symptom of PAD is intermittent claudication, a cramping pain in your legs that occurs during physical activity and subsides with rest. This pain signals that your muscles aren't receiving adequate blood flow due to narrowed arteries. Without sufficient HDL to remove cholesterol from these peripheral arteries, plaque continues to accumulate, potentially leading to complete blockages that can result in tissue death and amputation.

PAD also serves as a warning sign for problems elsewhere in your cardiovascular system. People with PAD are likely to have similar plaque buildup in their coronary and carotid arteries, significantly increasing their risk of heart attacks and strokes. The interconnected nature of your circulatory system means that low HDL affects your entire cardiovascular network.

Inflammatory Conditions and Immune System Impact

HDL cholesterol carries more than just cholesterol; it also transports anti-inflammatory and antioxidant enzymes that help protect your blood vessels from damage. When HDL levels are low, you lose this natural anti-inflammatory protection, leaving your cardiovascular system more vulnerable to the harmful effects of chronic inflammation.

Chronic inflammation plays a central role in the development of atherosclerosis, the process by which plaque builds up in your arteries. Without adequate HDL to combat inflammation, this process accelerates, leading to faster plaque formation and increased cardiovascular risk. Some research suggests that low HDL may also be linked to inflammatory conditions beyond the cardiovascular system, though heart disease remains the primary concern.

Kidney Disease and Other Organ Complications

Emerging research indicates that low HDL cholesterol may contribute to kidney disease and other organ complications. The kidneys contain numerous small blood vessels that can be damaged by the same processes that affect coronary arteries when HDL protection is inadequate. Some studies have found associations between low HDL levels and worse kidney function, though more research is needed to fully understand this relationship.

The connection between low HDL and kidney problems is particularly concerning for people with diabetes, who already face increased kidney disease risk. When low HDL combines with diabetes-related complications, the risk of kidney damage may be even higher, potentially leading to chronic kidney disease that requires dialysis or transplantation.

Who Is Most at Risk for Low HDL Cholesterol?

Several factors increase your likelihood of having dangerously low HDL cholesterol. Men are at significantly higher risk than women, with nearly three times as many men having low HDL levels. This difference is largely due to hormonal factors, particularly the protective effects of estrogen in women.

  • People with insulin resistance or type 2 diabetes
  • Individuals who are overweight or obese, especially with excess abdominal fat
  • Smokers and tobacco users
  • People with sedentary lifestyles
  • Those with diets high in refined carbohydrates and low in healthy fats
  • Individuals with certain genetic predispositions
  • People taking certain medications that can lower HDL

Ethnicity also plays a role in HDL levels and associated risks. Hispanic Americans have the highest rates of low HDL at nearly 25%, while Black Americans have the lowest rates at about 12%. However, it's important to note that having higher HDL doesn't guarantee protection from heart disease, as other risk factors also contribute to overall cardiovascular health.

The Importance of Regular Monitoring and Testing

Low HDL cholesterol is often called a "silent" risk factor because it typically doesn't cause symptoms until serious complications develop. The only way to know your HDL level is through blood testing. Current guidelines recommend cholesterol screening every five years for most adults, but more frequent testing may be necessary if you have risk factors or are making lifestyle changes to improve your levels.

Comprehensive cholesterol testing should include not just HDL, but also LDL cholesterol, triglycerides, and advanced markers like apolipoprotein B (ApoB) and apolipoprotein A1 (ApoA1). These additional markers provide a more complete picture of your cardiovascular risk and can help guide treatment decisions.

For people actively working to improve their HDL levels through lifestyle changes, more frequent monitoring every three to six months can help track progress and motivate continued healthy behaviors. This regular feedback allows you to see how diet, exercise, and other interventions are affecting your cholesterol profile.

Taking Action to Protect Your Health

Understanding the serious health risks associated with low HDL cholesterol is the first step toward protection. The good news is that HDL levels can often be improved through lifestyle modifications, and even modest increases can provide significant health benefits.

Regular aerobic exercise is one of the most effective ways to raise HDL cholesterol, with studies showing increases of 5-10% from consistent physical activity. Weight loss, particularly reducing abdominal fat, can also significantly boost HDL levels. Dietary changes, such as replacing refined carbohydrates with healthy fats and reducing sugar intake, can further improve your cholesterol profile.

If you smoke, quitting is crucial for HDL improvement and overall cardiovascular health. Smoking lowers HDL levels by about 5 mg/dL compared to non-smokers, and this effect can be reversed within months of cessation. Even moderate alcohol consumption has been shown to raise HDL levels, though this should be balanced against other health risks and is not recommended as a primary intervention.

While lifestyle changes are the foundation of HDL improvement, some people may need additional medical interventions. Your healthcare provider can help determine if medications or other treatments are necessary based on your overall risk profile and response to lifestyle modifications. The key is taking action before serious complications develop, as prevention is always more effective than treatment after disease has already occurred.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details